Screener
Amneal Pharmaceuticals, Inc. AMRX Gain (loss) on extinguishment of debt
Gain (loss) on extinguishment of debt at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other (expense) income: | ||||
| Interest expense, net | (55,043) | (65,101) | (108,404) | (122,040) |
| Foreign exchange (loss) gain, net | (1,950) | 8,256 | (9,750) | 12,503 |
| Loss on refinancing | — | — | (3,510) | — |
| Increase in tax receivable agreement liability | (2,439) | (4,420) | (106) | (15,107) |
| Other income, net | 653 | 1,604 | 1,395 | 2,122 |
| Total other expense, net | (58,779) | (59,661) | (120,375) | (122,522) |
| Income before income taxes | 70,990 | 51,711 | 151,166 | 89,197 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s gain (loss) on extinguishment of debt?
- Amneal Pharmaceuticals, Inc. (AMRX) reported gain (loss) on extinguishment of debt of $0 in Q2 2026.
- What does gain (loss) on extinguishment of debt mean?
- Gains or losses from retiring debt before maturity — gains when debt is repurchased below par, losses when premiums are paid for early redemption.
Ask your AI about Amneal Pharmaceuticals, Inc.'s gain (loss) on extinguishment of debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude